ISRCTN37385347已完成不适用
Prospective randomized blinded study evaluating ultrasound versus fluoroscopy guided sacral InterStim® lead placement
Metro Health Hospital0 个研究点目标入组 40 人开始时间: 2017年1月10日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Diagnosis of overactive bladder, non-obstructive urinary retention, or fecal incontinence
- •2. Aged 18 years or older
- •3. Failure of previous conservative measures (i.e. behavior modification, biofeedback, pelvic floor training, at least one antimuscarinic or beta-agonist medication)
- •4. Medically fit to undergo proposed surgery
- •5. Patient able to consent
排除标准
- •1. Pregnant or planning on becoming pregnant
- •2. Severe or uncontrolled diabetes with peripheral nerve involvement
- •3. Knowledge of planned MRI or other procedures precluding implantation of device or need for removal
- •4. Severe BPH, prostate cancer, urethral stricture, or other mechanical obstruction
- •5. Active urinary tract, skin, or soft tissue infection
研究者
相似试验
已完成
不适用
To see the effect of training in laparoscopy on the performance of surgery trainees in the operation theatreCTRI/2012/11/003113All India Institute of Medical Sciences20
已完成
不适用
Prospective randomized observer-blinded study comparing the analgesic efficacy of ultrasound-guided rectus sheath block to local anesthetic infiltration for laparoscopic percutaneous extraperitoneal closurelaparoscopic inguinal hernia surgery of children performed under general anesthesiaJPRN-UMIN000020912Hokkaido University34
尚未招募
2 期
A Study Comparing two drugs(Granisetron and Ramosetron ) in preventing low blood pressure in pregnant patients undergoing caesarean section under spinal anesthesia using hyperbaric levobupivacaine.CTRI/2024/03/063785Department of anaesthesiology
进行中（未招募）
不适用
A Randomized, Partially-blind Study to Evaluate the Safety, Tolerability and Effect on Virological Response of Treatment with the HCV Protease Inhibitor RO5190591 in Combinationwith Pegasys and Copegus for 12 or 24 weeks, versus treatment with Pegasys and Copegus alone, in Treatment-Na?ve Patients with Chronic Hepatitis C Genotype 1 Virus Infection. - NDChronic Hepatitis C (CHC) Genotype 1MedDRA version: 12.0Level: LLTClassification code 10008912Term: Chronic hepatitis CEUCTR2009-009608-38-ITF.Hoffmann-La Roche300
进行中（未招募）
1 期
A Randomized, Partially-blind Study to Evaluate the Safety, Tolerability and Effect on Virological Response of Treatment with the HCV Protease Inhibitor RO5190591 in combination with Pegasys and Copegus for 12 or 24 weeks, versus treatment with Pegasys and Copegus alone, in Treatment-Naïve Patients with Chronic Hepatitis C Genotype 1 Virus InfectioEUCTR2009-009608-38-FRF.Hoffmann-La Roche300